Clinical Study of TUTI-16 in Asymptomatic, HIV-1 Infected Subjects Effectively Controlled by Antiretroviral Therapy and the Effects on Viral Load During a Structured Treatment Interruption.
Phase of Trial: Phase I/II
Latest Information Update: 30 Oct 2017
At a glance
- Drugs TUTI 16 (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 12 Jul 2012 Actual end date (June 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.